06Mar 2019

RELATIONSHIP BETWEEN THE JNK PATHWAY AND APOPTOSIS IN HEART FAILURE.

  • Department of human antomy and histoembryology,Jiamusi University, Jiamusi,China.
  • College of basic Medicine , Jiamusi University , Jiamusi, China.
  • Department of Orthopedics, First affiliated Hospital of Jiamusi University, Jiamusi, China.
  • Department of Pediatrics,First affiliated Hospital of Jiamusi University, Jiamusi, China.
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

JNKs belong to mitogen activated protein kinases family and are involved in regulation of various cellular responses including cell survival, cell proliferation and differentiation. They can be activated by several factors such as radiation, stress, growth factors , cytokines and extracellular signals. JNKs activation results in phosphorylation of downstream molecules involve in normal cellular processes. Furthermore the recent data have linked JNK signaling with different pathological coditions, including inflammation, cancer , neurodegenrative disease and cardiac hypertrophy. Gq signaling initiates hypertrophic growth of neonatal rat cultured myocytes and is postulated to transduce in vivo cardiac pressure overload hypertrophy.however with the over expression of c-jun through Ap-1 and ATF-2 transcripting factor, it can cause decompensatory hypertrophy which can proceed to cardiac failure. This review analyzes our present understanding of the role of JNK in apoptotic signaling in heart failure and some other mechanism which induces apoptosis in cardiomyocytes.

  1. Widmann, C., Gibson, S., Jarpe, M.B., and Johnson, G.L. 1999. Mitogenactivated protein kinase: conservation of a three-kinase module from yeast to human. Physiol. Rev.79:143?180.
  2. Sugden, P.H., and Clerk, A. 1998. ?Stress-responsive? mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium. Circ. Res.83:345?352.
  3. Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell 2000; 103:239-52; PMID:11057897; http://dx.doi.org/10.1016/ S0092-8674(00)00116-1
  4. Weston CR, Davis RJ. The JNK signal transduction pathway. Curr Opin Genet Dev 2002; 12:1421; PMID:11790549; http://dx.doi.org/10.1016/ S0959-437X(01)00258-1
  5. Lin A, Dibling B. The true face of JNK activation in apoptosis. Aging Cell. 2002; 1:112?116. [PubMed: 12882340]
  6. Liu J, Lin A. Role of JNK activation in apoptosis: a double-edged sword. Cell Res. 2005; 15:36?42. [PubMed: 15686625]
  7. Devary Y, Gottlieb RA, Lau LF, Karin M. Rapid and preferential activation of the c-jun gene during the mammalian UV response. Mol Cell Biol 1991; 11:2804-11; PMID:1901948
  8. Hibi M, Lin A, Smeal T, Minden A, Karin M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 1993; 7:2135? 2148. [PubMed: 8224842]
  9. Fanger GR, Gerwins P, Widmann C, Jarpe MB, Johnson GL. MEKKs, GCKs, MLKs, PAKs, TAKs, and tpls: upstream regulators of the c-Jun aminoterminal kinases? Curr Opin Genet Dev 1997; 7:6774; PMID:9024636; http://dx.doi.org/10.1016/ S0959-437X(97)80111-6
  10. Yu C, Minemoto Y, Zhang J, Liu J, Tang F, Bui TN, Xiang J, Lin A. JNK suppresses apoptosis via phosphorylation of the proapoptotic Bcl-2 family protein BAD. Mol Cell 2004; 13:329-40; PMID:14967141;
  11. Lepp? S, Bohmann D. Diverse functions of JNK signaling and c-Jun in stress response and apoptosis. Oncogene 1999; 18:6158-62; PMID:10557107; http://dx.doi.org/10.1038/sj.onc.1203173
  12. Yu C, Minemoto Y, Zhang J, Liu J, Tang F, Bui TN, Xiang J, Lin A. JNK suppresses apoptosis via phosphorylation of the proapoptotic Bcl-2 family protein BAD. Mol Cell 2004; 13:329-40; PMID:14967141; http://dx.doi.org/10.1016/S1097-2765(04)00028-0
  13. Westwick JK, Weitzel C, Minden A, Karin M, Brenner DA. Tumor necrosis factor alpha stimulates AP-1 activity through prolonged activation of the c-Jun kinase. J Biol Chem. 1994; 269:26396? 26401. [PubMed: 7929360]
  14. Cano E, Hazzalin CA, Mahadevan LC. Anisomycin-activated protein kinases p45 and p55 but not mitogen-activated protein kinases ERK-1 and -2 are implicated in the induction of c-fos and c-jun. Mol Cell Biol. 1994; 14:7352?7362. [PubMed: 7935449]
  15. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007; 35:495?516. [PubMed: 17562483]
  16. Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell. 2000; 103:239?252. [PubMed: 11057897]
  17. Johnson GL, Nakamura K. The c-jun kinase/stress-activated pathway: regulation, function and role in human disease. Biochim Biophys Acta. 2007; 1773:1341?1348. [PubMed: 17306896]
  18. Dhanasekaran DN, Kashef K, Lee CM, Xu H, Reddy EP. Scaffold proteins of MAP-kinase modules. Oncogene. 2007; 26:3185?3202. Review. [PubMed: 17496915]
  19. Dhanasekaran N, Reddy EP. Signaling by dual specificity kinases. Oncogene. 1998; 17:1447?1755. [PubMed: 9779990
  20. Kyriakis JM, Brautigan DL, Ingebritsen TS, Avruch J. Pp54 microtubule-associated protein-2 kinase requires both tyrosine and serine/threonine phosphorylation for activity. J Biol Chem 1991;266:10043-6.
  21. Bode,A.M.,andDong,Z.(2007).ThefunctionalcontrarietyofJNK.MolCarcinog. 46, 591?598. doi: 10.1002/mc.20348
  22. Avruch, J. (2007). MAP kinase pathways: the first twenty years. Biochim. Biophys. Acta 1773, 1150?1160. doi: 10.1016/j.bbamcr.2006.11.006
  23. Patterson, K. I., Brummer, T., O?Brien, P. M., and Daly, R. J. (2009). Dualspecificity phosphatases: critical regulators with diverse cellular targets. Biochem. J. 418, 475?489. doi: 10.1042/BJ20082234
  24. Wagner, E. F., and Nebreda, A. R. (2009). Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer 9, 537?549. doi: 10.1038/nrc2694
  25. Fanger GR, Gerwins P, Widmann C, Jarpe MB, Johnson GL. MEKKs, GCKs, MLKs, PAKs, TAKs, and tpls: upstream regulators of the c-Jun amino-terminal kinases? Curr Opin Genet Dev. 1997; 7:67?74. [PubMed: 9024636]
  26. Wagner, E. F., and Nebreda, A. R. (2009). Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer 9, 537?549. doi: 10.1038/nrc2694
  27. Gupta,S.,Barrett,T.,Whitmarsh,A.J.,Cavanagh,J.,Sluss,H.K.,D?rijard,B.,etal. (1996). Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J. 15, 2760?2770.
  28. Davis, R. J. (2000). Signal transduction by the JNK group of MAP kinases. Cell 103, 239?252. doi: 10.1016/S0092-8674(00)00116-1
  29. Bogoyevitch MA, Gillespie-Brown J, Ketterman AJ, Fuller SJ, Ben-Levy R,Ashworth A, et al. Stimulation of the stress-activated mitogen-activated proteinkinase subfamilies in perfused heart. p38/RK mitogen-activated protein kinasesand c-Jun N-terminal kinases are activated by ischemia/reperfusion. Circ Res1996;79:162?73.
  30. Goldsmith ZG, Dhanasekaran DN. G protein regulation of MAPK networks. Oncogene2007;26:3122?42.
  31. Rose BA, Force T, Wang Y. Mitogen-activated protein kinase signaling in theheart: angels versus demons in a heart-breaking tale. Physiol Rev 2010;90:1507?4
  32. Pandur P, Lasche M, Eisenberg LM, Kuhl M. Wnt-11 activation of a non-canonicalWnt signalling pathway is required for cardiogenesis. Nature 2002;418:636?41
  33. Sugden PH, Clerk A. ?Stress-responsive? mitogen-activated protein kinases(c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in themyocardium. Circ Res 1998;83:345?52.
  34. Knight RJ, Buxton DB. Stimulation of c-Jun kinase and mitogen-activated proteinkinase by ischemia and reperfusion in the perfused rat heart. Biochem BiophysRes Commun 1996;218:83?8.
  35. Pellieux, C., Sauthier, T., Aubert, J. F., Brunner, H. R., and Pedrazzini, T. (2000) J. Hypertens. 18, 1307?1317
  36. Wang, Y., Su, B., Sah, V. P., Brown, J. H., Han, J., and Chien, K. R. (1998) J. Biol. Chem. 273, 5423?542
  37. agents. Cancer Lett. 2014; 344:174-179. 37. Chen YR, Meyer CF and Tan TH. Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in gamma radiationinduced apoptosis. J Biol Chem. 1996; 271:631-63
  38. Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, Bar-Sagi D, Jones SN, Flavell RA and Davis RJ. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science. 2000; 288:870-874
  39. Yang DD, Kuan CY, Whitmarsh AJ, Rincon M, Zheng TS, Davis RJ, Rakic P and Flavell RA. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature. 1997; 389:865-870.
  40. Chang L and Karin M. Mammalian MAP kinase signalling cascades. Nature. 2001; 410:37-40.
  41. Turjanski AG, Vaque JP and Gutkind JS. MAP kinases and the control of nuclear events. Oncogene. 2007; 26:32403253.
  42. Fan M and Chambers TC. Role of mitogen-activated protein kinases in the response of tumor cells to chemotherapy. Drug Resist Updat. 2001; 4:253-267.
  43. Johnson GL and Nakamura K. The c-jun kinase/stressactivated pathway: regulation, function and role in human disease. Biochim Biophys Acta. 2007; 1773:1341-1348.
  44. Bjorkblom B, Vainio JC, Hongisto V, Herdegen T, Courtney MJ and Coffey ET. All JNKs can kill, but nuclear localization is critical for neuronal death. J Biol Chem. 2008; 283:19704-19713
  45. Fuchs SY, Adler V, Buschmann T, Yin Z, Wu X, Jones SN and Ronai Z. JNK targets p53 ubiquitination and degradation in nonstressed cells. Genes Dev. 1998; 12:2658-2663
  46. Oleinik NV, Krupenko NI and Krupenko SA. Cooperation between JNK1 and JNK2 in activation of p53 apoptotic pathway. Oncogene. 2007; 26:7222-7230.
  47. Jones EV, Dickman MJ and Whitmarsh AJ. Regulation of p73-mediated apoptosis by c-Jun N-terminal kinase. Biochem J. 2007; 405:617-623
  48. Lei K, Nimnual A, Zong WX, Kennedy NJ, Flavell RA, Thompson CB, Bar-Sagi D and Davis RJ. The Bax subfamily of Bcl2-related proteins is essential for apoptotic signal transduction by c-Jun NH(2)-terminal kinase. Mol Cell Biol. 2002; 22:4929-4942.
  49. Mandal M, Olson DJ, Sharma T, Vadlamudi RK and Kumar R. Butyric acid induces apoptosis by up-regulating Bax expression via stimulation of the c-Jun N-terminal kinase/ activation protein-1 pathway in human colon cancer cells. Gastroenterology. 2001; 120:71-78.
  50. Tsuruta F, Sunayama J, Mori Y, Hattori S, Shimizu S, Tsujimoto Y, Yoshioka K, Masuyama N and Gotoh Y. JNK promotes Bax translocation to mitochondria through phosphorylation of 14-3-3 proteins. EMBO J. 2004; 23:1889-1899.
  51. Adams JM and Cory S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene. 2007; 26:13241337.
  52. Lei K and Davis RJ. JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc Natl Acad Sci U S A. 2003; 100:2432-2437.
  53. Marani M, Tenev T, Hancock D, Downward J and Lemoine NR. Identification of novel isoforms of the BH3 domain protein Bim which directly activate Bax to trigger apoptosis. Mol Cell Biol. 2002; 22:3577-3589.
  54. Hubner A, Barrett T, Flavell RA and Davis RJ. Multisite phosphorylation regulates Bim stability and apoptotic activity. Mol Cell. 2008; 30:415-425.
  55. Donovan N, Becker EB, Konishi Y and Bonni A. JNK phosphorylation and activation of BAD couples the stressactivated signaling pathway to the cell death machinery. J Biol Chem. 2002; 277:40944-40949
  56. Sunayama J, Tsuruta F, Masuyama N and Gotoh Y. JNK antagonizes Akt-mediated survival signals by phosphorylating 14-3-3. J Cell Biol. 2005; 170:295-304.
  57. Yamamoto K, Ichijo H and Korsmeyer SJ. BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M. Mol Cell Biol. 1999; 19:8469-8478.
  58. Walczak H. Death receptor-ligand systems in cancer, cell death, and inflammation. Cold Spring Harb Perspect Biol. 2013; 5:a008698.
  59. Jin HO, Park IC, An S, Lee HC, Woo SH, Hong YJ, Lee SJ, Park MJ, Yoo DH, Rhee CH and Hong SI. Up-regulation of Bak and Bim via JNK downstream pathway in the response to nitric oxide in human glioblastoma cells. J Cell Physiol. 2006; 206:477-486.
  60. Chen YJ, Liu WH, Kao PH, Wang JJ and Chang LS. Involvement of p38 MAPK- and JNK-modulated expression of Bcl-2 and Bax in Naja nigricollis CMS-9induced apoptosis of human leukemia K562 cells. Toxicon. 2010; 55:1306-1316
  61. Zou W, Liu X, Yue P, Zhou Z, Sporn MB, Lotan R, Khuri FR and Sun SY. c-Jun NH2-terminal kinase-mediated upregulation of death receptor 5 contributes to induction of apoptosis by the novel synthetic triterpenoid methyl-2cyano-3,12-dioxooleana-1, 9-dien-28-oate in human lung cancer cells. Cancer Res. 2004; 64:7570-7578.
  62. Silke J and Meier P. Inhibitor of apoptosis (IAP) proteinsmodulators of cell death and inflammation. Cold Spring Harb Perspect Biol. 2013; 5.
  63. Deng Y, Ren X, Yang L, Lin Y and Wu X. A JNK-dependent pathway is required for TNFalpha-induced apoptosis. Cell. 2003; 115:61-70
  64. Prakasam A, Ghose S, Oleinik NV, Bethard JR, Peterson YK, Krupenko NI and Krupenko SA. JNK1/2 regulate Bid by direct phosphorylation at Thr59 in response to ALDH1L1. Cell Death Dis. 2014; 5:e1358
  65. Simon, M. I., Strathmann, M. P. & Gautam, N. (1991) Science 252, 802?808.
  66. Post, G. R. & Brown, J. H. (1996) FASEB J. 10, 741?749.
  67. Sadoshima, J.-I. & Izumo, S. (1993) Circ. Res. 73, 413?423.
  68. Grossman,W.,Jones,D.&McLaurin,L.P.(1975)J.Clin.Invest. 55, 56?64
  69. Milano, C. A., Dolbert, P. C., Rockman, H. A., Bond, R. A., Venable,M.E.,Allen,L.F.&Lefkowitz,R.J.(1994)Proc.Natl. Acad. Sci. USA 91, 10109?10113
  70. D?Angelo, D. D., Sakata, Y., Lorenz, J. N., Boivin, G. P., Walsh, R. A., Liggett, S. B. & Dorn G. W., II (1997) Proc. Natl. Acad. Sci. USA 94, 8121?8126
  71. Narula, J., Haider, N., Virmani, R., DiSalvo, T. G., Kolodgie, F. D., Hajjar, R. J., Schmidt, U., Semigran, M. J., Dec, G. W. & Khaw, B.-A. (1996) N. Engl. J. Med. 335, 1182?1189.
  72. Fliss, H. & Gattinger, D. (1996) Circ. Res. 79, 949?956.
  73. Pellieux, C., Sauthier, T., Aubert, J. F., Brunner, H. R., and Pedrazzini, T. (2000) J. Hypertens. 18, 1307?1317
  74. Wang, Y., Su, B., Sah, V. P., Brown, J. H., Han, J., and Chien, K. R. (1998) J. Biol. Chem. 273, 5423?5426
  75. ?Aoki, H., Kang, P. M., Hampe, J., Yoshimura, K., Noma, T., Matsuzaki, M., and Izumo, S. (2002) J. Biol. Chem. 277, 10244?10250
  76. Petrich, B. G., Gong, X., Lerner, D. L., Wang, X., Brown, J. H., Saffitz, J. E., and Wang, Y. (2002) Circ. Res. 91, 640?647
  77. Barker, R. J., and Gourdie, R. G. (2002) Circ. Res. 91, 556?558
  78. Molkentin JD, Dorn 2nd GW. Cytoplasmic signaling pathways that regulate cardiac hypertrophy.Annu Rev Physiol 2001;63:391?426
  79. GarringtonTP, Johnson GL. Organization and regulation of mitogenactivated protein kinase signaling pathways. Curr Opin Cell Biol 1999;11:211?8.
  80. Lenormand P, Sardet C, Pages G, L?Allemain G, BrunetA, Pouyssegur J. Growth factors induce nuclear translocation of MAP kinases (p42mapkandp44mapk)butnotoftheiractivatorMAPkinasekinase (p45mapkk) in fibroblasts. J Cell Biol 1993;122:1079?88.
  81. Davis R. Signal transduction by the JNK group of MAP kinase. Cell 2000;103:239?52
  82. GuptaS,BarrettT,WhitmarshAJ,CavanaghJ,SlussHK,DerijardB, et al. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J 1996;15:2760?70.
  83. Ito M, Yoshioka K, Akechi M, Yamashita S, Takamatsu N, Sugiyama K, et al. JSAP1, a novel Jun N-terminal protein kinase (JNK)bindingproteinthatfunctionsasascaffoldfactorintheJNKsignaling pathway. Mol Cell Biol 1999;19:7539?48
  84. Johnson NL, Gardner AM, Diener KM, Lange-Carter CA, Gleavy J, Jarpe MB, et al. Signal transduction pathways regulated by mitogenactivated/extracellular response kinase kinase kinase induce cell death. J Biol Chem 1996;271:3229?37.
  85. YanoM,KimS,IzumiY,YamanakaS,IwaoH.Differentialactivation of cardiac c-Jun amino-terminal kinase and extracellular signalregulated kinase in ang II-mediated hypertension. Circ Res 1998;83: 752?60.
  86. RamirezMT,SahVP,ZhaoXL,HunterJJ,ChienKR,BrownJH.The MEKK?JNK pathway is stimulated by a-adrenergic receptor and ras activationandisassociatedwithinvitroandinvivocardiachypertrophy. J Biol Chem 1997;72:14057?61.
  87. WangY, Su B, SahVP, Brown JH, Han J, Chien KR. Cardiac hypertrophy induced by mitogen-activated protein kinase kinase 7, a specific activator for c-Jun NH2-terminal kinase in ventricular muscle cells. J Biol Chem 1998;273:5423?6.
  88. Choukroun G, Hajjar R, Kyriakis JM, Bonventre JV, Rosenzweig A. Force T. Role of the stress-activated protein kinases in endothelininducedcardiomyocytehypertrophy.JClinInvest1998;102:1311?20.
  89. ChoukrounG,HajjarR,FryS,DelMonteF,HaqS,GuerreroJL,etal. Regulation of cardiac hypertrophy in vivo by the stress-activated proteinkinases/c-JunNH(2)-terminalkinases.JClinInvest1999;104: 391?8.
  90. Sadoshima J, Montagne O, Wang Q,Yang G, Warden J, Liu J, et al. The MEKK1?JNK pathway plays a protective role in pressure overloadbutdoesnotmediatecardiachypertrophy.JClinInvest2002;110: 271?9.
  91. MinaminoT,YujiriT,TeradaN,TaffetGE,MichaelLH,JohnsonGL, et al. MEKK1 is essential for cardiac hypertrophy and dysfunction induced by Gq. Proc NatlAcad Sci USA 2002;99:3866?71.
  92. Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, et al. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 2000;288:870?4.
  93. Yang DD, Kuan CY,WhitmarshAJ, Rincon M, Zheng TS, Davis RJ, et al. Absence of excito toxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 1997;389:865?70.
  94. Sabapathy K, Hu Y, Kallunki T, Schreiber M, David JP, Jochum W, etal.JNK2isrequiredforefficientT-cellactivationandapoptosisbut not for normal lymphocyte development. Curr Biol 1999;9:116?25.
  95. Sabapathy K, Hu Y, Kallunki T, Schreiber M, David JP, Jochum W, etal.JNK2isrequiredforefficientT-cellactivationandapoptosisbut not for normal lymphocyte development. Curr Biol 1999;9:116?25.
  96. KuanCY,YangDD,SamantaRoyDR,DavisRJ,RakicP,FlavellRA. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 1999;22:667?76.
  97. Minamino T, Yujiri T, Papst PJ, Chan ED, Johnson GL, Terada N. MEKK1 suppresses oxidative stress-induced apoptosis of embryonic stem cell-derived cardiac myocytes. Proc Natl Acad Sci USA 1999; 96:15127?32.
  98. Yujiri T, Sather S, Fanger GR, Johnson GL. Role of MEKK1 in cell survivalandactivationofJNKandERKpathwaysdefinedbytargeted gene disruption. Science 1998;282:1911?4
  99. Andreka P, Zang J, Dougherty C, Slepak TI, Webster KA, Bishopric NH. Cytoprotection by Jun kinase during nitric oxide-induced cardiac myocyte apoptosis. Circ Res 2001;88:305?12.
  100. Dougherty CJ, Kubasiak LA, Prentice H, Andreka P, Bishopric NH, WebsterKA.Activationofc-JunN-terminalkinasepromotessurvival of cardiac myocytes after oxidative stress. Biochem J 2002;362:561? 71.
  101. GabaiVL,MeriinAB,YaglomJA,WeiJY,MosserDD,ShermanMY. Suppression of stress kinase JNK is involved in HSP72-mediated protection of
  102. Kwon SH, Pimentel DR, Remondino A, Sawyer DB, Colucci WS. H(2)O(2) regulates cardiac myocyte phenotype via concentrationdependent activation of distinct kinase pathways. J Mol Cell Cardiol 2003;35:615?21.
  103. Yamaguchi O, Higuchi Y, Hirotani S, Kashiwase K, Nakayama H, Hikoso S, et al. Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling. Proc Natl Acad Sci USA 2003;100:15883?8.
  104. Remondino A, Kwon SH, Communal C, Pimentel DR, Sawyer DB, Singh K, et al.b-adrenergic receptor-stimulated apoptosis in cardiac myocytesismediatedbyreactiveoxygenspecies/c-JunNH2-terminal kinase-dependent activation of the mitochondrial pathway. Circ Res 2003;92:136?8.
  105. Aoki H, Kang PM, Hampe J,Yoshimura K, Noma T, Matsuzaki M, etal.Directactivationofmitochondrialapoptosismachinerybyc-Jun N-terminal kinase in adult cardiac myocytes. J Biol Chem 2002;277: 10244?50.
  106. Baines CP, Zhang J, Wang GW, Zheng YT, Xiu JX, Cardwell EM, et al. Mitochondrial PKCe and MAPK form signaling modules in the murineheart:enhancedmitochondrialPKCe?MAPKinteractionsand differentialMAPKactivationinPKCe-inducedcardioprotection.Circ Res 2002;90:390?7.
  107. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK?p38 MAP kinases on apoptosis. Science 1995;270:1326?31
  108. Yamamoto K, Ichijo H, Korsmeyer SJ. Bcl-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M. Mol Cell Biol 1999;19:8469?78.
  109. Donovan N, Becker EB, Konishi Y, Bonni A. JNK phosphorylation and activation of Bad couples the stress-activated signaling pathway to the cell death machinery. J Biol Chem 2002;277:40944?9.
  110. DengY, Ren X,Yang L, LinY, Wu X. A JNK-dependent pathway is required for TNFa-induced apoptosis. Cell 2003;115:61?70
  111. LeiK,DavisRJ.JNKphosphorylationofBim-relatedmembersofthe Bcl2 family induces Bax-dependent apoptosis. Proc Natl Acad Sci USA 2003;100:2432?7.

[Zhao Junpeng, Tian Guozhong, Ahmad Zaki Barati and Santosh Adhikari. (2019); RELATIONSHIP BETWEEN THE JNK PATHWAY AND APOPTOSIS IN HEART FAILURE. Int. J. of Adv. Res. 7 (Mar). 385-394] (ISSN 2320-5407). www.journalijar.com

zhao jun peng

DOI:

Article DOI: 10.21474/IJAR01/8647      
DOI URL: https://dx.doi.org/10.21474/IJAR01/8647

Download Full Paper

Download PDF No. of Downloads: 19 | No. of Views: 84